If you ask AP bio students about organelles in a eukaryotic cell, they’d (hopefully) list the usual: the powerhouse mitochondria, the genetic control center of the nucleus and all the other cellular machinery humming away to keep our bodies alive. But if you asked them about the hemifusome, you’d likely be met with confusion. It’s not in any biology textbook, nor is it in the current knowledge base of most students and teachers. That’s what makes it so exciting, as the hemifusome is a recently identified organelle, and its discovery could be the key to gaining many insights into neurodegenerative diseases.

What is the Hemifusome?

The hemifusome is a transient intermediate organelle that forms during the process of membrane fusion in cells. It is not a permanent structure such as the mitochondria or nucleus, but rather a highly regulated assembly that exists for milliseconds to facilitate the precise exchange of materials.

This process is driven by SNARE proteins, which act like molecular zippers, bringing cargo vesicles to the target cell membrane in close contact. However, biological membranes are not single layers, but rather double-walled layers called lipid bilayers. For a vesicle to release its chemical cargo, both walls of the membrane must be breached in a controlled manner.

The hemifusome represents the intermediate moment when this breach begins. It is the state of hemifusion, in which the outer layers of the two bilayers have only merged, creating a single and continuous lipid monolayer between the vesicle and plasma membrane. The inner membranes, however, remain distinct, allowing lipids to mix between the two but keep their aqueous content separate. The diaphragm acts as a molecular gatekeeper that requires a specific, regulated trigger to proceed to full fusion. The final step involves the fusion pore separating, allowing chemical cargo to be released into the extracellular space or a new cellular compartment. The hemifusome ultimately has the role of cellular hesitation, ensuring proper communication and transport inside the cell.

Insights & Future Pathways

The phenomenon of two vesicles merging (hemifusion) has been theorized for years, but the stable organelle formed by this process had never been directly discovered until modern advances in 2025. This is partly because hemifusomes operate on a nanoscale level during intracellular transport, and their transient nature means they often disappear or are destroyed by chemical preparation methods before traditional imaging techniques can capture them.

Recent breakthroughs in cyro-electron tomography (cyro-ET) were key to their discovery. At a three-dimensional level, cyro-ET flash-freezes cells and observes them under high molecular resolution, revealing previously unseen structures such as the hemifusome. Scientists’ long-held predictions were visually confirmed, revealing vesicles merging to form a hemifusion diaphragm. By observing that they are stable and functional units within the cell, their repeatable structure confirms them as a newly identified organelle for transport and communication.

The hemifusome offers a new lens for understanding neurodegenerative diseases such as Alzheimer’s and Parkinson’s. For example, if this organelle is essential for cellular communication and exchange of materials in neuronal cells, dysfunction could be a key role in toxic protein accumulation. By targeting the hemifusome’s machinery, future therapies could aim to restore the cleanup system of hemifusomes which could potentially halt degeneration before irreparable damage occurs.